Luye Pharma Group Ltd
HKEX:2186
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Luye Pharma Group Ltd
HKEX:2186
|
CN |
|
G
|
Globe Trade Centre SA
JSE:GTC
|
PL |
|
Fastighets AB Balder
STO:BALD B
|
SE |
|
Opera Ltd
NASDAQ:OPRA
|
NO |
|
Celularity Inc
NASDAQ:CELU
|
US |
|
M
|
Momentum Group AB
STO:MMGR B
|
SE |
|
Air Canada
TSX:AC
|
CA |
|
A
|
Amplefield Ltd
SGX:AOF
|
MY |
Multiples-Based Value
The Multiples-Based Value of one
Luye Pharma Group Ltd
stock under the Base Case scenario is
hidden
HKD.
Compared to the current market price of 2.51 HKD,
Luye Pharma Group Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Luye Pharma Group Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Luye Pharma Group Ltd
HKEX:2186
|
9.4B HKD | 1.3 | 20.9 | 4.2 | 6.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD | 13.3 | 42.1 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD | 6.2 | 22 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
227.8B GBP | 5.3 | 30.4 | 16.8 | 23.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF | 5.4 | 21.7 | 13.4 | 17.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD | 2.6 | 20.5 | 7.8 | 10.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.5 | 17.3 | 7.3 | 9 |